|
HY-141572-10mg
|
MedChemexpress LLC
|
1,2-Dioleoyl-sn-glycerol [CAS 24529-88-2]
|
|
|
|
|
HY-130240-10mg
|
MedChemexpress LLC
|
GCN2-IN-6 [CAS 2183470-09-7]
|
|
Cancer-Kinase/protease
|
|
|
HY-130240-100mg
|
MedChemexpress LLC
|
GCN2-IN-6 [CAS 2183470-09-7]
|
|
Cancer-Kinase/protease
|
|
|
HY-130240-5mg
|
MedChemexpress LLC
|
GCN2-IN-6 [CAS 2183470-09-7]
|
|
Cancer-Kinase/protease
|
|
|
HY-130240-50mg
|
MedChemexpress LLC
|
GCN2-IN-6 [CAS 2183470-09-7]
|
|
Cancer-Kinase/protease
|
|
|
HY-130240-1mL
|
MedChemexpress LLC
|
GCN2-IN-6 [CAS 2183470-09-7] (10mM in DMSO)
|
|
Cancer-Kinase/protease
|
|
|
HY-103254-10mg
|
MedChemexpress LLC
|
ML221 [CAS 877636-42-5]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-103254-100mg
|
MedChemexpress LLC
|
ML221 [CAS 877636-42-5]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-103254-25mg
|
MedChemexpress LLC
|
ML221 [CAS 877636-42-5]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-103254-5mg
|
MedChemexpress LLC
|
ML221 [CAS 877636-42-5]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-103254-50mg
|
MedChemexpress LLC
|
ML221 [CAS 877636-42-5]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-103254-1mL
|
MedChemexpress LLC
|
ML221 [CAS 877636-42-5] (10mM in DMSO)
|
|
Neuroscience-Neuromodulation
|
|
|
HY-126077-1mg
|
MedChemexpress LLC
|
MTI-31 [CAS 1567915-38-1]
|
|
COVID-19-immunoregulation
|
|
|
HY-126077-10mg
|
MedChemexpress LLC
|
MTI-31 [CAS 1567915-38-1]
|
|
COVID-19-immunoregulation
|
|
|
HY-126077-100mg
|
MedChemexpress LLC
|
MTI-31 [CAS 1567915-38-1]
|
|
COVID-19-immunoregulation
|
|
|
HY-126077-25mg
|
MedChemexpress LLC
|
MTI-31 [CAS 1567915-38-1]
|
|
COVID-19-immunoregulation
|
|
|
HY-126077-5mg
|
MedChemexpress LLC
|
MTI-31 [CAS 1567915-38-1]
|
|
COVID-19-immunoregulation
|
|
|
HY-126077-50mg
|
MedChemexpress LLC
|
MTI-31 [CAS 1567915-38-1]
|
|
COVID-19-immunoregulation
|
|
|
HY-109066-10mg
|
MedChemexpress LLC
|
Olinciguat [CAS 1628732-62-6]
|
|
COVID-19-immunoregulation
|
|
|
HY-109066-100mg
|
MedChemexpress LLC
|
Olinciguat [CAS 1628732-62-6]
|
|
COVID-19-immunoregulation
|
|
|
HY-109066-5mg
|
MedChemexpress LLC
|
Olinciguat [CAS 1628732-62-6]
|
|
COVID-19-immunoregulation
|
|
|
HY-109066-50mg
|
MedChemexpress LLC
|
Olinciguat [CAS 1628732-62-6]
|
|
COVID-19-immunoregulation
|
|
|
HY-109066-1mL
|
MedChemexpress LLC
|
Olinciguat [CAS 1628732-62-6] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
|
HY-122026-10mg
|
MedChemexpress LLC
|
PF-04802367 [CAS 1962178-27-3]
|
|
Neuroscience-Neurodegeneration
|
|
|
HY-122026-100mg
|
MedChemexpress LLC
|
PF-04802367 [CAS 1962178-27-3]
|
|
Neuroscience-Neurodegeneration
|
|
